continu see lot opportun horizon share gain quest
analyst day clearli overshadow compani lower forecast
challeng year quest view new issu neg
surpris disappoint compani reduc guidanc
earn said believ merit stick thesi
near-term given major catalyst nation payor network open access quest
short leash deliv commit also view
appropri reflect valuat price-to-earnings point continu
view risk/reward profil posit skew reiter ow rate
cfo mark guinan elabor lower forecast quest announc
thursday night compani note primari driver reduct
relat increas reserv associ revenu account receiv
quest said updat guidanc floor want establish
level anoth neg surpris
look near-term quest frame improv health plan access one
greatest opportun compani last decad view
open aetna network first time sinc
opportun quest labcorp consolid share fragment lab
industri quest size share gain opportun around billion compani
think could drive upsid new long-term growth compound-annual-growth-rate
revenu growth earn growth account order lab
test quest see short-term target describ loyalist
mix beyond compani medium-term target
anoth long-term total target sinc june quest note
contact account
lower usd
return equiti ttm
includ takeaway present includ dx view coverag
link barclay live interact chart
action lower forecast beyond pt
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
overweight believ quest long
runway deliv strategi acceler growth
deliv oper excel point new
payor relationship help drive lab test share
toward nation lab time addit
believ quest meaning leverag
diagnost data asset custom
upsid case assum quest aggreg
increment test share drive upsid
case ep earn begin
acceler believ multipl room
expans well given long runway
downsid case assum softer util
well increment wage pressur busi
cost repres downsid
case ep
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
continu see lot opportun horizon share gain quest
analyst day clearli overshadow compani lower forecast
challeng year quest view new issu neg
surpris disappoint compani reduc guidanc
earn said believ merit stick thesi near
term given major catalyst nation payor network open access quest
short leash deliv near-term commit also view
appropri reflect valuat price-to-earnings point continu view
risk/reward profil posit skew reiter overweight rate
lower forecast beyond due lower outlook
subsequ lower jump point futur growth specif quest lower
revenu forecast impli revenu
prior forecast ep lower
previous impli ep prior forecast
forecast ep previous lower
ep forecast annual
lower outlook also lower price target
price repres blend blend ep scenario analysi
also yield roughli multipl ep forecast prior price target
repres prior blend ep scenario analysi
upsid downsid scenario analysi price
consist forecast
cfo mark guinan elabor lower forecast quest announc
thursday night compani note primari driver reduct
relat increas reserv associ revenu account receiv
cfo mark guinan discuss compani process reserv relat revenu
account receiv accrual process quest make assumpt around
collect base histori well updat inform around payor mix price
compani also consid rate denial well abil bill patient directli
claim adjud quest also consid whether get paid directli
payor patient quest describ sever reason appar
epsmultipleoutcomerel pricenotesbas lab share revenue upsid epsdownsid volum wage pressur barclay quest diagnost
compani updat guidanc earn dso increas
day y/i compani note differ mix busi day
period compani undergo lab convers histor extend
cash convers cash collect improv novemb compani
mechan took closer analysi decid make adjust conjunct
analyst day simpli roll full million revenu reduct incom
statement impli tax adjust ep impact impli biggest issu
reserv adjust smaller driver reduc guidanc relat
volum soft driven sever natur disast
specif quest highlight hurrican michael california wildfir recent east
coast snowstorm quest said updat guidanc floor
want establish level anoth neg surpris
quest also provid addit commentari compani long-term outlook
target revenu growth compound-annual-growth-rate earn growth
compound-annual-growth-rate quest also commit revenu earn growth new
baselin revenu growth consist forecast
quest note expect revenu compound-annual-growth-rate strateg
midpoint quest earn growth forecast modestli impli
growth compound-annual-growth-rate consist top end forecast earn
acceler reimburs headwind pama abat
assum growth similar
forecast would impli roughli compound-annual-growth-rate compar forecast
quest note forecast assum medicar cut pama persist
think subsid agre base prior survey well
recent methodolog chang includ hospit outreach lab next
survey quest wide expect updat long-term object believ
ultim could conservat embed mid-to-high single-digit
forecast depend consolid tailwind payor quest analyst
day compani project mid-to-high single-digit earn growth
introduct pama dampen effect toward lower end rang
mid single-digit note earn growth forecast earn
per share forecast note quest announc commit return major
free cash flow sharehold repurchas dividend ep growth could
ultim modestli faster earn growth
network updat state
jim davi evp gener diagnost everett cunningham
svp commerci organ opportun
health plan health system
quest frame improv health plan access one greatest opportun
compani last decad view open
aetna network first time sinc opportun quest labcorp
consolid share fragment lab industri quest size share gain opportun
around billion compani think could drive upsid new
long-term growth compound-annual-growth-rate revenu growth earn
growth new relationship unitedhealthcar horizon
georgia quest ad total million increment live quest believ
market share plan today goal reach share
posit line commerci share current in-network plan end
given new live repres billion revenu opportun share
would impli billion revenu goal payor next three year quest
outlin six state account live see improv
network access quest alreadi strong california texa florida
new york compani see major improv georgia new jersey
addit georgia horizon respect
address opportun quest plan focu valu proposit
employ patient physician quest provid drug screen servic
employ work save money lab re-direct help keep
employe healthi well screen patient becom bigger
consum healthcar compani focus provid conveni access
retail strategi digit enabl afford price importantli quest plan
leverag network access improv simplic physician offic gain share
custom quest elabor compani physician target strategi
compani evalu account order laboratori test
current activ custom within total quest see short-term target
describ loyalist mix beyond compani
medium-term target anoth long-term total target sinc june
quest note contact account
quest activ pipelin hospit opportun span refer test
laboratori cost optim servic outreach acquisit compani believ
tool help health system deal challeng laboratori industri
includ deceler revenu steadi cost growth shrink laboratori margin
cunningham provid detail cost structur typic laboratori
cost come ancillari servic laboratori spend quest
believ work hospit improv effici across three vertic
refer test billion opportun quest believ leader
hospit refer test billion revenu impli roughli
market share segment compani focus penetr market
test hospit often outsourc due cost consider lack capabl
quest believ clinic leadership advanc solut addit test insight
quest provid hospit custom experi differenti
compani area compani leverag four esoter laboratori genet
counselor servic rep provid qualiti servic refer test quest
work hospit repres hospit
health system
lab manag optim billion compani profession
laboratori servic pl offer quest focus address billion
hospit lab spend servic span wide rang consult relationship
full servic laboratori servic quest bring equip employe
run laboratori compani improv effici custom
optim test menu figur insourc versu outsourc leverag
supplier contract implement advanc data solut quest pl
relationship believ pipelin opportun add growth
hospit outreach acquisit billion quest work hospit manag
help understand financi outreach laboratori primari
function hospit laboratori provid inpati servic outreach
laboratori becom cost center hospit opportun monet
laboratori sell quest enter jv quest believ long tail
opportun outreach transact top outreach laboratori
repres market simpl integr process deal allow
compani string togeth sever smaller transact could add contribut
meaning
quest view advanc diagnost futur healthcar thu signific
growth driver manner size advanc diagnost opportun note
quest alreadi leader quest relationship across healthcar landscap
help establish hub advanc diagnost given quest wealth
knowledg area member health system hospit often reach quest
question regard advanc diagnost addit quest focus
perform advanc diagnost profit way long histori work
payor quest know present result drive reimburs addit
quest work patient make sure understand implic genet result
well best way proceed treatment
manner note quest scale help compani abil innov within
advanc diagnost intern compani util network advanc laboratori
high level autom addit compani conduct numer
center expertis across countri exampl quest lab san juan capistrano
hub genet expertis acquisit reprosourc provid quest
center fertil assess expertis partnership anoth import way
quest drive innov quest current util partnership develop
offer liquid biopsi artifici intellig importantli manner note quest
often approach partnership opportun compani look increas
promot technolog furthermor quest commit way
drive innov final quest global dx network partnership lab around
world network quest share import practic sophist
lab around world
 quest highlight cancer genet women health neurolog area
would like continu expand presenc given emerg technolog
guidelin support improv reimburs view categori natur
potenti growth driver neurolog quest expand one area view
interest brain health traumat brain injuri banyan biomark privat
earn fda approv first ivd test earli wall street journal
cathi doherti svp clinic franchis solut
driven consumer movement healthcar quest focus strategi
becom laboratori provid choic consum compani focus
number initi design take advantag fact patient
control healthcar decis greater econom incent addit
patient increasingli demand conveni overal superior experi quest
outlin number initi
retail strategi place patient servic center psc retail locat quest
offer conveni effici comfort environ consum
compani plan expand retail footprint psc
futur part retail footprint locat safeway wal-mart locat
quest current partnership feedback relationship posit
digit solut quest focus increas interact patient
digit solut myquest app patient schedul appoint
receiv test result electron mobil devic addit quest offer
person content help patient better engag health also
quest servic provid exampl compani send patient remind
schedul next appoint advertis certain test differ patient group
 hcv screen babi boomer
health home health initi quest send sampl collect kit
patient home improv conveni patient allow access
laboratori servic without travel psc program menu
expand throughout end includ consum test
athlet launch colorect screen health well
consumer-direct test patient take control healthcar quest
offer differ test packag avail state mean
consum dont need test direct physician allow go
on-line order test quest provid physician assist facilit test
order interpret compani size market million grow
double-digit
dermot shortgen svp strategi ventur dr
dermot shortgen discuss quest vari util data asset importantli
quest data robust use varieti player differ purpos
exampl shortgen note quest data help track effect
pre-market post-market pharma launch specif shortgen ad quest
data effect augment script data addit quest provid data number
area public sector fact compani recent renew contract
cdc quest believ monitor diseas popul heat map help
aid public health health plan commun outreach
addit quest begun util data clinic trial recruit shortgen
note quest healthcar provid hipaa allow compani reach
patient directli regard clinic trial believ quest signific
opportun drive clinic trial recruit elig patient
notifi clinic trial physician addit quest believ
util psc clinic trial gener conveni particip
travel investig site although quest jv iqvia assist number
pharma compani clinic trial quest size opportun
market billon grow annual
dr jay wohlgemuth describ quest focu lower cost self insur
employ wohlgemuth note employ spend healthcar increas
annual work self-insur provid quest tout blueprint well
lower cost wohgemuth provid number way data util lower
healthcar spend exampl quest identifi patient like diabet
patient point right direct obtain necessari treatment
compani found major custom appreci servic run
valu base model fee servic
present conclud discuss surround quest strategi drive
cost save overal quest believ number chang relat digit
drive save next year
davi discuss quest initi reduc bad debt greater
specif stress import real-tim adjud
offer test patient quest immedi determin much patient
requir pay out-of-pocket patient decid would like proceed
test real-tim adjud specif import given common
reason unpaid lab bill patient realiz co-pay
choos ignor test cover insur addit quest
focus shift away paper requisit david note cost quest roughli
per requisit labor paper requisit enter comput paper
requisit current account requisit addit paper
requisit lack inform requir order gain reimburs quest
also offer digit suit physician order drive lower bad debt rate sampl
collect outsid quest lab
davi also expand increas effici associ patient check
psc tablet patient find process easi also free time
phlebotomist addit quest util data tablet determin
extra phlebotomist station furthermor patient provid background
inform book appoint on-line save time offic
davi ad quest also consolid work core lab immunoassay
platform shave year compani note
fleet immunoassay instrument exce instrument compani run
test annual current vendor compani show slide present
includ abbott architect beckman coulter unicel diasorin liason-
xl ortho-clin dx vitro roch coba siemen advia centaur
immulit quest also see opportun extend approach molecular test
well time compani recent extend women health test contract
referenc compani earn call quest also
custom roch viral load test final compani build state
art lab clifton nj pool volum daili lab region
facil featur high level autom increas product
site consolid test teterboro nj lab well lab baltimor
transofrm potenti impact patient pre-registr appoint offic center barclay quest diagnost
million except per share dataestestestestestestestestestincom increas debt debt debt gross lab increas equival organ increas net margin net sg net comp sg net increas intang oper ebitda margin net oper profit ebit margin net interest expens debt share earn joint expens pre-tax pre-tax provis incom tax net net average share average share ep ep increas item net net increas ens net incom growth net ep growth barclay quest diagnost
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
